We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+7.9%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$218M
AUM Growth
+$7.19M
Cap. Flow
-$6.19M
Cap. Flow %
-2.85%
Top 10 Hldgs %
29.01%
Holding
178
New
31
Increased
32
Reduced
56
Closed
32

Top Buys

Rank Stock Value
1
LULU icon
lululemon athletica
LULU
+$1.99M
2
GEV icon
GE Vernova
GEV
+$1.94M
3
COF icon
Capital One
COF
+$1.52M
4
ARW icon
Arrow Electronics
ARW
+$1.52M
5
DHI icon
D.R. Horton
DHI
+$1.35M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$3.92M
2
UNH icon
UnitedHealth
UNH
+$2.06M
3
TOL icon
Toll Brothers
TOL
+$1.98M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.57M

Sector Composition

Rank Sector Weight
1 Industrials 21.6%
2 Technology 15.11%
3 Healthcare 14.51%
4 Financials 12.59%
5 Consumer Discretionary 12.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPG icon
101
Simon Property Group
SPG
$66B
$582K 0.27%
3,100
MDT icon
102
Medtronic
MDT
$120B
$580K 0.27%
6,088
-700
-10% -$64.3K
PATK icon
103
Patrick Industries
PATK
$2.27B
$578K 0.27%
5,586
-75
-1% -$7.88K
WMT icon
104
Walmart Inc
WMT
$858B
$577K 0.27%
5,599
LHX icon
105
L3Harris
LHX
$46.5B
$550K 0.25%
1,800
TRMB icon
106
Trimble
TRMB
$13.7B
$534K 0.25%
6,544
-8,796
-57% -$718K
MMM icon
107
3M
MMM
$84.9B
$520K 0.24%
3,350
-25
-0.7% -$3.85K
AZN icon
108
AstraZeneca
AZN
$251B
$514K 0.24%
3,349
-4,626
-58% -$700K
APD icon
109
Air Products & Chemicals
APD
$64.7B
$484K 0.22%
1,775
-250
-12% -$72.4K
UNH icon
110
UnitedHealth
UNH
$337B
$458K 0.21%
1,325
-6,795
-84% -$2.06M
ALL icon
111
Allstate
ALL
$65B
$429K 0.2%
2,000
XYL icon
112
Xylem
XYL
$25.1B
$405K 0.19%
2,744
DHR icon
113
Danaher
DHR
$147B
$400K 0.18%
+2,020
New +$402K
TTWO icon
114
Take-Two Interactive
TTWO
$39.6B
$400K 0.18%
+1,550
New +$367K
HEI icon
115
HEICO Corp
HEI
$41.5B
$395K 0.18%
+1,225
New +$390K
INTU icon
116
Intuit
INTU
$88B
$393K 0.18%
575
-11
-2% -$7.93K
MC icon
117
Moelis & Co
MC
$4.51B
$387K 0.18%
5,425
-9,950
-65% -$710K
COIN icon
118
Coinbase
COIN
$45.4B
$380K 0.17%
+1,125
New +$381K
APA icon
119
APA Corp
APA
$16.6B
$379K 0.17%
+15,626
New +$330K
IBKR icon
120
Interactive Brokers
IBKR
$40.2B
$378K 0.17%
+5,500
New +$346K
AB icon
121
AllianceBernstein
AB
$3.36B
$378K 0.17%
9,900
GIS icon
122
General Mills
GIS
$19.6B
$373K 0.17%
7,400
-725
-9% -$36.4K
CELH icon
123
Celsius Holdings
CELH
$6.99B
$371K 0.17%
+6,450
New +$337K
QSR icon
124
Restaurant Brands International
QSR
$26.3B
$356K 0.16%
5,549
-2,400
-30% -$158K
AMD icon
125
Advanced Micro Devices
AMD
$823B
$352K 0.16%
+2,175
New +$351K

Similar funds

New England Research & Management's Q3 2025 Portfolio in Review

As of Q3 2025, New England Research & Management held 178 positions worth $218M, up 3.4% from $211M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

New England Research & Management's Q3 2025 filing shows 31 new, 32 increased, 56 reduced and 32 closed positions. Its largest new stake was lululemon athletica: 9,950 shares worth $1.77M. The largest sale was Goldman Sachs, an estimated $3.92M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

  • New England Research & Management's largest Q3 2025 buy was lululemon athletica: 9,950 shares worth $1.77M.
  • New England Research & Management added most to GE Vernova in Q3 2025, an estimated $1.94M increase.
  • New England Research & Management's biggest Q3 2025 reduction was Goldman Sachs, cutting an estimated $3.92M.
  • New England Research & Management fully exited Teradyne in Q3 2025, selling an estimated $1.55M.
  • New England Research & Management's ten largest holdings make up 29% of its $218M portfolio in Q3 2025.
  • New England Research & Management opened 31 new positions and closed 32 in Q3 2025.
  • New England Research & Management's portfolio value rose 3.4% quarter-over-quarter to $218M.

Based on New England Research & Management's 13F filing for Q3 2025, filed 6 Oct 2025.